These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 9792857)
1. Phenotype-genotype relationships in complementation group 3 of the peroxisome-biogenesis disorders. Chang CC; Gould SJ Am J Hum Genet; 1998 Nov; 63(5):1294-306. PubMed ID: 9792857 [TBL] [Abstract][Full Text] [Related]
2. Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders. Warren DS; Morrell JC; Moser HW; Valle D; Gould SJ Am J Hum Genet; 1998 Aug; 63(2):347-59. PubMed ID: 9683594 [TBL] [Abstract][Full Text] [Related]
4. Novel mutations in the PEX12 gene of patients with a peroxisome biogenesis disorder. Gootjes J; Schmohl F; Waterham HR; Wanders RJ Eur J Hum Genet; 2004 Feb; 12(2):115-20. PubMed ID: 14571262 [TBL] [Abstract][Full Text] [Related]
5. Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders. Chang CC; Lee WH; Moser H; Valle D; Gould SJ Nat Genet; 1997 Apr; 15(4):385-8. PubMed ID: 9090384 [TBL] [Abstract][Full Text] [Related]
6. Phenotype-genotype relationships in peroxisome biogenesis disorders of PEX1-defective complementation group 1 are defined by Pex1p-Pex6p interaction. Tamura S; Matsumoto N; Imamura A; Shimozawa N; Suzuki Y; Kondo N; Fujiki Y Biochem J; 2001 Jul; 357(Pt 2):417-26. PubMed ID: 11439091 [TBL] [Abstract][Full Text] [Related]
7. PEX12 interacts with PEX5 and PEX10 and acts downstream of receptor docking in peroxisomal matrix protein import. Chang CC; Warren DS; Sacksteder KA; Gould SJ J Cell Biol; 1999 Nov; 147(4):761-74. PubMed ID: 10562279 [TBL] [Abstract][Full Text] [Related]
8. PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders. Liu Y; Björkman J; Urquhart A; Wanders RJ; Crane DI; Gould SJ Am J Hum Genet; 1999 Sep; 65(3):621-34. PubMed ID: 10441568 [TBL] [Abstract][Full Text] [Related]
9. PEX12, the pathogenic gene of group III Zellweger syndrome: cDNA cloning by functional complementation on a CHO cell mutant, patient analysis, and characterization of PEX12p. Okumoto K; Shimozawa N; Kawai A; Tamura S; Tsukamoto T; Osumi T; Moser H; Wanders RJ; Suzuki Y; Kondo N; Fujiki Y Mol Cell Biol; 1998 Jul; 18(7):4324-36. PubMed ID: 9632816 [TBL] [Abstract][Full Text] [Related]
10. Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation. Matsumoto N; Tamura S; Furuki S; Miyata N; Moser A; Shimozawa N; Moser HW; Suzuki Y; Kondo N; Fujiki Y Am J Hum Genet; 2003 Aug; 73(2):233-46. PubMed ID: 12851857 [TBL] [Abstract][Full Text] [Related]
11. Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels. Walter C; Gootjes J; Mooijer PA; Portsteffen H; Klein C; Waterham HR; Barth PG; Epplen JT; Kunau WH; Wanders RJ; Dodt G Am J Hum Genet; 2001 Jul; 69(1):35-48. PubMed ID: 11389485 [TBL] [Abstract][Full Text] [Related]
12. Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders. Shimozawa N; Suzuki Y; Zhang Z; Imamura A; Toyama R; Mukai S; Fujiki Y; Tsukamoto T; Osumi T; Orii T; Wanders RJ; Kondo N Hum Mol Genet; 1999 Jun; 8(6):1077-83. PubMed ID: 10332040 [TBL] [Abstract][Full Text] [Related]
13. Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I. Tamura S; Okumoto K; Toyama R; Shimozawa N; Tsukamoto T; Suzuki Y; Osumi T; Kondo N; Fujiki Y Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4350-5. PubMed ID: 9539740 [TBL] [Abstract][Full Text] [Related]
14. Identification of the molecular defect in patients with peroxisomal mosaicism using a novel method involving culturing of cells at 40 degrees C: implications for other inborn errors of metabolism. Gootjes J; Schmohl F; Mooijer PA; Dekker C; Mandel H; Topcu M; Huemer M; Von Schütz M; Marquardt T; Smeitink JA; Waterham HR; Wanders RJ Hum Mutat; 2004 Aug; 24(2):130-9. PubMed ID: 15241794 [TBL] [Abstract][Full Text] [Related]
15. A novel PEX12 mutation identified as the cause of a peroxisomal biogenesis disorder with mild clinical phenotype, mild biochemical abnormalities in fibroblasts and a mosaic catalase immunofluorescence pattern, even at 40 degrees C. Zeharia A; Ebberink MS; Wanders RJA; Waterham HR; Gutman A; Nissenkorn A; Korman SH J Hum Genet; 2007; 52(7):599-606. PubMed ID: 17534573 [TBL] [Abstract][Full Text] [Related]
16. Genomic structure of PEX13, a candidate peroxisome biogenesis disorder gene. Björkman J; Stetten G; Moore CS; Gould SJ; Crane DI Genomics; 1998 Dec; 54(3):521-8. PubMed ID: 9878256 [TBL] [Abstract][Full Text] [Related]
17. Novel PEX1 mutations and genotype-phenotype correlations in Australasian peroxisome biogenesis disorder patients. Maxwell MA; Allen T; Solly PB; Svingen T; Paton BC; Crane DI Hum Mutat; 2002 Nov; 20(5):342-51. PubMed ID: 12402331 [TBL] [Abstract][Full Text] [Related]